• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼠白血病细胞内在生长异质性是其对生长抑制性抗癌药物敏感性差异的基础。

Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.

机构信息

Department of Basic Science, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.

Research Center for Complex Systems Biology, The University of Tokyo, Tokyo, Japan.

出版信息

PLoS One. 2021 Feb 1;16(2):e0236534. doi: 10.1371/journal.pone.0236534. eCollection 2021.

DOI:10.1371/journal.pone.0236534
PMID:33524064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7850478/
Abstract

Cancer cell populations consist of phenotypically heterogeneous cells. Growing evidence suggests that pre-existing phenotypic differences among cancer cells correlate with differential susceptibility to anticancer drugs and eventually lead to a relapse. Such phenotypic differences can arise not only externally driven by the environmental heterogeneity around individual cells but also internally by the intrinsic fluctuation of cells. However, the quantitative characteristics of intrinsic phenotypic heterogeneity emerging even under constant environments and their relevance to drug susceptibility remain elusive. Here we employed a microfluidic device, mammalian mother machine, for studying the intrinsic heterogeneity of growth dynamics of mouse lymphocytic leukemia cells (L1210) across tens of generations. The generation time of this cancer cell line had a distribution with a long tail and a heritability across generations. We determined that a minority of cell lineages exist in a slow-cycling state for multiple generations. These slow-cycling cell lineages had a higher chance of survival than the fast-cycling lineages under continuous exposure to the anticancer drug Mitomycin C. This result suggests that heritable heterogeneity in cancer cells' growth in a population influences their susceptibility to anticancer drugs.

摘要

癌细胞群体由表型异质的细胞组成。越来越多的证据表明,癌细胞之间预先存在的表型差异与对抗癌药物的不同敏感性相关,并最终导致复发。这种表型差异不仅可以由细胞周围环境的异质性外部驱动,也可以由细胞内在的波动内部驱动。然而,在恒定的环境下,内在表型异质性出现的定量特征及其与药物敏感性的相关性仍然难以捉摸。在这里,我们使用微流控设备哺乳动物母机研究了数十代小鼠淋巴细胞白血病细胞 (L1210) 生长动力学的内在异质性。该癌细胞系的代时分布具有长尾和跨代遗传。我们确定少数细胞谱系在多个代时处于缓慢循环状态。与连续暴露于抗癌药物丝裂霉素 C 相比,这些缓慢循环的细胞谱系在持续暴露于抗癌药物丝裂霉素 C 时具有更高的存活机会。这一结果表明,癌细胞群体中生长的遗传性异质性会影响其对抗癌药物的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/572aa73a4e77/pone.0236534.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/7ad66ba41bf1/pone.0236534.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/cc9eb91ad036/pone.0236534.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/572aa73a4e77/pone.0236534.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/7ad66ba41bf1/pone.0236534.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/cc9eb91ad036/pone.0236534.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/7850478/572aa73a4e77/pone.0236534.g003.jpg

相似文献

1
Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug.鼠白血病细胞内在生长异质性是其对生长抑制性抗癌药物敏感性差异的基础。
PLoS One. 2021 Feb 1;16(2):e0236534. doi: 10.1371/journal.pone.0236534. eCollection 2021.
2
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.新型青蒿素、莪术醇和姜黄素衍生杂合化合物对多药耐药白血病细胞的作用。
Molecules. 2018 Apr 6;23(4):841. doi: 10.3390/molecules23040841.
3
Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.介电泳微流控芯片可用于对异质性急性髓系白血病患者样本中的多药耐药进行单细胞测量。
Anal Chem. 2016 Jun 7;88(11):5680-8. doi: 10.1021/acs.analchem.5b04446. Epub 2016 May 17.
4
Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.在人类结肠癌细胞中,抗癌药物耐药性的获得与癌症干性部分相关。
Int J Oncol. 2016 Dec;49(6):2558-2568. doi: 10.3892/ijo.2016.3725. Epub 2016 Oct 7.
5
Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.Ras 关联结构域家族蛋白 1 A 亚型的甲基化与肝癌细胞系 SMMC - 7721 的增殖和耐药性相关。
J Gastroenterol Hepatol. 2007 May;22(5):683-9. doi: 10.1111/j.1440-1746.2006.04676.x.
6
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.索拉非尼耐药白血病细胞中的代谢重编程和氧化还原适应:通过非靶向代谢组学和稳定同位素示踪分析检测到。
Cancer Commun (Lond). 2019 Apr 4;39(1):17. doi: 10.1186/s40880-019-0362-z.
7
mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both and .mTORC1/2 抑制剂在抑制小鼠淋巴细胞白血病生长方面是一种更理想的药物。
Anticancer Res. 2019 Sep;39(9):4829-4835. doi: 10.21873/anticanres.13668.
8
Pharmacological effect of aminoferrocene in mice with L1210 leukemia.氨基二茂铁对L1210白血病小鼠的药理作用。
Exp Oncol. 2015 Jun;37(2):120-5.
9
Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.内源性转化生长因子-β2触发的基质细胞衍生因子-1-趋化因子受体4信号轴对骨髓播散肿瘤细胞的耐药性和慢周期状态至关重要。
Oncotarget. 2015 Jan 20;6(2):1008-19. doi: 10.18632/oncotarget.2826.
10
MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.混合谱系白血病(MLL)部分串联重复白血病细胞对小分子DOT1L抑制敏感。
Haematologica. 2015 May;100(5):e190-3. doi: 10.3324/haematol.2014.115337. Epub 2015 Jan 16.

引用本文的文献

1
Simultaneous Plate-Reader Characterization of Promoter Activity and Cell Growth in Engineered Mammalian Cells.同时在工程化哺乳动物细胞中利用板读仪检测启动子活性和细胞生长。
Methods Mol Biol. 2024;2844:85-96. doi: 10.1007/978-1-0716-4063-0_5.
2
Mammalian cell growth characterisation by a non-invasive plate reader assay.利用非侵入式平板读数仪分析哺乳动物细胞的生长特性。
Nat Commun. 2024 Jan 2;15(1):57. doi: 10.1038/s41467-023-44396-4.
3
A unified framework for measuring selection on cellular lineages and traits.用于测量细胞谱系和特征选择的统一框架。

本文引用的文献

1
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.mTOR 信号调控应激诱导的突变,促进癌症中的适应性进化。
Science. 2020 Jun 5;368(6495):1127-1131. doi: 10.1126/science.aau8768.
2
Hidden long-range memories of growth and cycle speed correlate cell cycles in lineage trees.生长和周期速度的隐藏长程记忆与谱系树中的细胞周期相关。
Elife. 2020 Jan 23;9:e51002. doi: 10.7554/eLife.51002.
3
Adaptive mutability of colorectal cancers in response to targeted therapies.结直肠癌对靶向治疗的适应性突变。
Elife. 2022 Dec 6;11:e72299. doi: 10.7554/eLife.72299.
4
Microfluidics for long-term single-cell time-lapse microscopy: Advances and applications.用于长期单细胞延时显微镜的微流控技术:进展与应用
Front Bioeng Biotechnol. 2022 Oct 12;10:968342. doi: 10.3389/fbioe.2022.968342. eCollection 2022.
5
Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies.嵌合抗原受体 T 细胞疗法治疗 B 细胞血液系统恶性肿瘤后的复发机制及治疗策略。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221118413. doi: 10.1177/15330338221118413.
Science. 2019 Dec 20;366(6472):1473-1480. doi: 10.1126/science.aav4474. Epub 2019 Nov 7.
4
The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies.单细胞技术揭示的肿瘤生态系统的空间和基因组层次结构
Trends Cancer. 2019 Jul;5(7):411-425. doi: 10.1016/j.trecan.2019.05.009. Epub 2019 Jun 18.
5
Leveraging and coping with uncertainty in the response of individual cells to therapy.利用和应对个体细胞对治疗的反应中的不确定性。
Curr Opin Biotechnol. 2018 Jun;51:109-115. doi: 10.1016/j.copbio.2017.12.007. Epub 2017 Dec 27.
6
Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance.肿瘤细胞内在的表型可塑性促进适应性细胞重编程,驱动获得性耐药。
J Cell Commun Signal. 2018 Mar;12(1):133-141. doi: 10.1007/s12079-017-0435-1. Epub 2017 Nov 30.
7
Tumour heterogeneity and resistance to cancer therapies.肿瘤异质性与癌症治疗耐药性。
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94. doi: 10.1038/nrclinonc.2017.166. Epub 2017 Nov 8.
8
A slow-cycling subpopulation of melanoma cells with highly invasive properties.具有高度侵袭性的黑素瘤细胞的慢周期亚群。
Oncogene. 2018 Jan 18;37(3):302-312. doi: 10.1038/onc.2017.341. Epub 2017 Sep 18.
9
Aging, mortality, and the fast growth trade-off of Schizosaccharomyces pombe.粟酒裂殖酵母的衰老、死亡率与快速生长权衡
PLoS Biol. 2017 Jun 20;15(6):e2001109. doi: 10.1371/journal.pbio.2001109. eCollection 2017 Jun.
10
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.罕见细胞变异性和药物诱导的重编程作为癌症耐药的一种模式。
Nature. 2017 Jun 15;546(7658):431-435. doi: 10.1038/nature22794. Epub 2017 Jun 7.